November 10, 2003
Takeda's US Subsidiary to Start Copromotion of Kos' Antihyperlipidemics Takeda Chemical Industries, Ltd. announced on November 4 that its 100%-owend subsidiary in the US, Takeda Pharmaceuticals North America, Inc. (TPNA), has made a copromotion agreement with Kos Pharmaceuticals, Inc. for...read more